|
|
Precisely Shaped Acoustic Ablation of Tumors Under 3D Ultrasound Image Guidance
|
3R44CA134169-04S1
|
$82,590
|
$82,590
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
|
Precisely Shaped Acoustic Ablation of Tumors Under 3D Ultrasound Image Guidance
|
5R44CA134169-04
|
$935,233
|
$935,233
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
|
Prospective Oral HPV and Risk of Head and Neck Cancers
|
1R21CA152785-01A1
|
$175,934
|
$175,934
|
BURK, ROBERT
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Targeted therapy of pancreatic cancer with in vivo radionuclide generator
|
1R21CA156088-01
|
$180,525
|
$180,525
|
DADACHOVA, EKATERINA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
DNA mismatch repair and cancer in murine models
|
5R01CA076329-14
|
$379,585
|
$379,585
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Proton-coupled folate/antifolate transport
|
5R01CA082621-13
|
$517,054
|
$517,054
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
MR Spectroscopy to Evaluate Liver Repopulation by Transplanted Hepatocytes
|
5R33CA121051-04
|
$466,808
|
$466,808
|
GUHA, CHANDAN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
The transcriptional basis of tumor promotion
|
5R01CA104292-08
|
$354,879
|
$354,879
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
HEPADNAVIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA
|
5R01CA037232-27
|
$491,862
|
$491,862
|
Rogler, Charles
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-37
|
$99,689
|
$10,966
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Novel Methods for Molecular Analysis of Colorectal Cancer Tissue
|
5R44CA121473-04
|
$524,547
|
$524,547
|
Han, James
|
AMBERGEN, INC
|
|
|
Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays
|
1R43CA161965-01
|
$149,865
|
$74,933
|
Lim, Mark
|
AMBERGEN, INC
|
|
|
Expression-Based Multi-Gene Signatures for CRC Recurrence and Chemoselection
|
5R44CA119565-06
|
$999,610
|
$999,610
|
Sears, Christopher
|
AMBERGEN, INC
|
|
|
Community Clinical Oncology Program
|
5U10CA037422-24
|
$4,282,002
|
$642,300
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RTOG Biospecimen Repository
|
2U24CA114734-06
|
$1,040,063
|
$312,019
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-35S1
|
$2,923,989
|
$263,159
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RTOG Tissue Bank
|
3U24CA114734-05S2
|
|
$0
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-35
|
$10,630,221
|
$956,720
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
American College of Radiology Imaging Network
|
5U01CA080098-13
|
$7,455,878
|
$3,727,939
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Targeted tumoricidal bacteria
|
5R44CA126023-03
|
$386,199
|
$96,550
|
ZHAO, MING
|
ANTICANCER, INC.
|
|
|
Multi-functional Esophaeal Theranostic Delivery System
|
N43CO110053-000
|
$20,000
|
$20,000
|
SHENOY, NARMADA
|
ARAVASC, INC.
|
|
|
A Center for the Convergence of Physical Science and Cancer Biology
|
4U54CA143862-03
|
$1,715,390
|
$1,715,390
|
Davies, Paul
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Engineered self-destructing Salmonella as a colorectal cancer cure
|
5R21CA152456-02
|
$193,043
|
$193,043
|
Kong, Wei
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Storytelling for Colorectal Health among Latinos
|
5R01CA118663-05
|
$469,333
|
$469,333
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Preclinical Development of iRGD for Pancreatic Cancer
|
1R43CA162766-01
|
$416,564
|
$416,564
|
Slee, Deborah
|
ASPYRIAN THERAPEUTICS, INC.
|
|
|
Identification of microRNA Biomarkers for Colon Cancer Recurrence Risk Stratifica
|
4R44CA138038-03
|
$590,860
|
$590,860
|
Mambo, Elizabeth
|
ASURAGEN, INC.
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-22
|
$406,165
|
$60,925
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
PDX-1 is a Therapeutic Target for Pancreatic Cancer
|
5R01CA095731-09
|
$266,570
|
$266,570
|
BRUNICARDI, FRANCIS
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Guideline-based surveillance and treatment of hepatocellular carcinoma
|
1R01CA160738-01
|
$292,264
|
$292,264
|
Davila, Jessica
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Obesity, H pylori and Risk of Barrett's Esophagus
|
5R01CA116845-05
|
$505,005
|
$505,005
|
El-Serag, Hashem
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Advanced glycation end products and colorectal cancer risk in women
|
1R03CA156626-01
|
|
$0
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
BRIT1, A NOVEL HEPATOCELLULAR CARCINOMA TUMOR SUPPRESSOR
|
1R21CA161513-01
|
$205,277
|
$205,277
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Reducing Missed And Delayed Diagnoses In Cancer: Lessons From Aviation
|
5K23CA125585-05
|
$141,750
|
$46,778
|
SINGH, HARDEEP
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Role of Age in Liver Cancer
|
1R01CA159942-01A1
|
$324,738
|
$324,738
|
TIMCHENKO, NIKOLAI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Regulation of cell growth by RNA binding proteins
|
5R01CA100070-09
|
$258,839
|
$258,839
|
TIMCHENKO, NIKOLAI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-16
|
$332,512
|
$332,512
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
|
JC Virus and Human Colorectal Neoplasia
|
5R01CA098572-07
|
$267,374
|
$267,374
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$62,667
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-13
|
$95,412
|
$10,495
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Spatial and Temporal Regulation of Angiogenesis
|
5P01CA092644-08
|
$1,606,344
|
$80,317
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Regulation of hepatic NKT cells by CDld+ liver cells
|
5R21CA143748-02
|
$183,549
|
$183,549
|
EXLEY, MARK
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
|
5U01CA151925-02
|
$648,725
|
$648,725
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Inhibition of angiogenesis by thrombospondin-1 (A2)
|
4R01CA130895-03
|
$348,364
|
$348,364
|
LAWLER, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Optimizing localized therapy for primary liver cancer: a clinical trial and model
|
5K23CA139005-03
|
$169,199
|
$169,199
|
Miksad, Rebecca
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
5R01CA102142-07
|
$330,937
|
$109,209
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Role of NFAT and NFAT-Induced Genes in Carcinoma
|
5R01CA096710-08
|
$295,224
|
$147,612
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
5K08CA129204-04
|
$135,270
|
$67,635
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-02S1
|
$140,000
|
$14,000
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-02S2
|
$299,726
|
$29,973
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
|
The MB-CCOP at Boston Medical Center
|
5U10CA139519-02
|
$685,482
|
$68,548
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
Total relevant funding to Digestive Diseases for this search: $464,562,457
|
